Overview
Basic information about this protein and its source genome.
- Accession
- PA3308
- Gene
- hepA PA3308 rapA
- Status
- annotated
- Amino acids
- 950
- Structure source
- AlphaFold
Target profile
Computed evidence for target prioritization.
- Human off-target
- hit
- Human identity (%)
- 30.256
- Human E-value
- 1.45e-06
- Gut microbiome off-target
- hit
- Essential (DEG)
- N
- Localization
- Cytoplasmic
Selected Druggability evidence
Selected Druggability is the FPocket score chosen for ranking using the curated structure priority. The 3D viewer may show a different loaded structure, so its visible pockets can differ.
Sequence
Primary amino-acid sequence viewer.
Functional Annotations
Enzyme classification and Gene Ontology terms linked to this protein.
Enzyme Commission (EC)
1Gene Ontology (GO)
10- GO:0005524 Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
- GO:0003682 Binding to chromatin, the network of fibers of DNA, protein, and sometimes RNA, that make up the chromosomes of the eukaryotic nucleus during interphase.
- GO:0003677 Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).
- GO:0004386 Catalysis of the reaction: ATP + H2O = ADP + phosphate, to drive the unwinding of a DNA or RNA helix.
- GO:0016817 Catalysis of the hydrolysis of any acid anhydride.
- GO:0140750 A histone octamer slider activity that spaces nucleosomes along chromosomal DNA. This activity is involved in assembling chromatin in uniform nucleosome arrays to regulate transcription by RNA polymerases I, II, and III, as well as DNA replication, recombination and repair.
- GO:0031507 An epigenetic gene silencing mechanism in which chromatin is compacted into heterochromatin, resulting in a chromatin conformation refractory to transcription. This process starts with heterochromatin nucleation, its spreading, and ends with heterochromatin boundary formation.
- GO:0045944 Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
- GO:0006355 Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription.
- GO:0140658 An activity, driven by ATP hydrolysis, that modulates the contacts between histones and DNA, resulting in a change in chromosome architecture within the nucleosomal array, leading to chromatin remodeling.
Sequence Features
Domain/signature hits from InterPro and related databases.
Show feature table
| Start | End | DB | Term | Name |
|---|---|---|---|---|
| 590 | 948 | Pfam | PF12137 | RNA polymerase recycling family C-terminal |
| 590 | 948 | InterPro | IPR022737 | RNA polymerase recycling, bacterial, C-terminal |
| 880 | 900 | Coils | Coil | Coil |
| 473 | 594 | CDD | cd18793 | SF2_C_SNF |
| 4 | 950 | Hamap | MF_01821 | RNA polymerase-associated protein RapA [rapA]. |
| 4 | 950 | InterPro | IPR023949 | RNA polymerase-associated protein RapA |
| 698 | 774 | Gene3D | G3DSA:3.30.360.80 | - |
| 151 | 348 | SMART | SM00487 | ultradead3 |
| 151 | 348 | InterPro | IPR014001 | Helicase superfamily 1/2, ATP-binding domain |
| 272 | 632 | SUPERFAMILY | SSF52540 | P-loop containing nucleoside triphosphate hydrolases |
| 272 | 632 | InterPro | IPR027417 | P-loop containing nucleoside triphosphate hydrolase |
| 477 | 586 | Pfam | PF00271 | Helicase conserved C-terminal domain |
| 477 | 586 | InterPro | IPR001650 | Helicase, C-terminal |
| 475 | 629 | ProSiteProfiles | PS51194 | Superfamilies 1 and 2 helicase C-terminal domain profile. |
| 475 | 629 | InterPro | IPR001650 | Helicase, C-terminal |
| 858 | 937 | Gene3D | G3DSA:6.10.140.1500 | - |
| 465 | 619 | Gene3D | G3DSA:3.40.50.300 | - |
| 465 | 619 | InterPro | IPR027417 | P-loop containing nucleoside triphosphate hydrolase |
| 4 | 56 | Gene3D | G3DSA:2.30.30.140 | - |
| 154 | 348 | SUPERFAMILY | SSF52540 | P-loop containing nucleoside triphosphate hydrolases |
| 154 | 348 | InterPro | IPR027417 | P-loop containing nucleoside triphosphate hydrolase |
| 58 | 115 | Gene3D | G3DSA:2.30.30.930 | - |
| 502 | 586 | SMART | SM00490 | helicmild6 |
| 502 | 586 | InterPro | IPR001650 | Helicase, C-terminal |
| 169 | 389 | Pfam | PF00176 | SNF2-related domain |
| 169 | 389 | InterPro | IPR000330 | SNF2, N-terminal |
| 6 | 56 | Pfam | PF18339 | RapA N-terminal Tudor like domain 1 |
| 6 | 56 | InterPro | IPR040765 | RapA, N-terminal Tudor like domain 1 |
| 165 | 333 | ProSiteProfiles | PS51192 | Superfamilies 1 and 2 helicase ATP-binding type-1 domain profile. |
| 165 | 333 | InterPro | IPR014001 | Helicase superfamily 1/2, ATP-binding domain |
| 58 | 119 | Pfam | PF18337 | RapA N-terminal Tudor like domain |
| 58 | 119 | InterPro | IPR040766 | RapA, N-terminal Tudor-like domain 2 |
| 155 | 344 | CDD | cd18011 | DEXDc_RapA |
| 620 | 669 | Gene3D | G3DSA:6.10.140.2230 | - |
| 171 | 337 | PANTHER | PTHR45766 | DNA ANNEALING HELICASE AND ENDONUCLEASE ZRANB3 FAMILY MEMBER |
| 151 | 430 | Gene3D | G3DSA:3.40.50.10810 | - |
| 151 | 430 | InterPro | IPR038718 | SNF2-like, N-terminal domain superfamily |
3D Structure
Selected loaded structure. Experimental PDB entries may cover only a portion of the sequence; predicted models typically cover the full protein.
Loading 3D structure...
Structural evidence
0 + 1Experimental PDB entries and predicted models. Click Switch to display a different structure in the viewer.
| Entry | Method | Resolution | Chain | Coverage | Links | Status |
|---|---|---|---|---|---|---|
|
AlphaFold
PA3308
|
AlphaFold | — | — | full sequence | — | Viewing |
Pocket details FPocket · P2Rank — toggle visibility and zoom from here, or open full viewer
Pockets (FPOCKET)
Showing top-ranked FPocket candidates by druggability. Druggability is color-coded: high (0.7 or higher), medium (0.4 to 0.69), low (below 0.4).
| FPOCKET | Sticks | Spheres | Surfaces | Druggability | Labels | Zoom | Positions |
|---|---|---|---|---|---|---|---|
| 3 | 0.287 | ||||||
| 1 | 0.283 |
Ligand evidence
Ligands grouped by evidence source. PDB ligands keep the source crystal visible, and loaded crystals can be opened directly in the structure viewer.
Highest-confidence structural evidence: ligands co-crystallized with this exact protein. If the source PDB is loaded in TPW, use Open crystal to inspect it in the structure viewer.
No PDB structure with a co-crystallized ligand found for this exact protein.
Structural evidence inferred from similar proteins. The source crystal indicates where the ligand was observed; the UniProt column identifies the homologous protein carrying that ligand.
| Ligand | Source crystal | UniProt (homolog) | MW · LogP · TPSA | Lipinski | PAINS | SMILES |
|---|---|---|---|---|---|---|
| BEF | P38144 | 66.0 Da LogP 0.88 TPSA 0.0 | ✓ Ro5 | ✓ Clean |
[Be-](F)(F)F
|
Experimental bioactivity from ChEMBL measured directly on this protein. Score = pchembl (−log Ki/IC₅₀; higher = more potent).
No ChEMBL bioactivity data found for this exact protein.
Bioactivity inferred from similar proteins in ChEMBL. Score = pchembl (−log Ki/IC₅₀; higher = more potent).
No ChEMBL hits found through similar proteins.
Proposed virtual-screening candidates from ZINC. Score = Tanimoto similarity to a known binder (0–1; higher = more similar).
No virtual-screening candidates for this protein.
PDB and ChEMBL records on this protein are shown in full. ChEMBL records from similar proteins are capped at the top 100 per protein (by pchembl) and ZINC at the top 50 (Tanimoto ≥ 0.5). ADME columns are descriptor-based screening flags, not experimental toxicity results.